About US
Contact us
-
Lilly settles long-running lawsuit tying Cymbalta to teen's suicideEli Lilly ($LLY) has battled to protect its best-selling drug, the antidepressant Cymbalta, against generic competition but has decided not to stand and fight a lawsuit tying it to the suicide of a 12013/4/11
-
Vivus investor says FDA move on Qsymia isn't enoughAt least one Vivus ($VVUS) shareholder isn't convinced that loosening FDA restrictions on a new obesity pill will fuel sales in any significant way. First Manhattan, which owns a 9.1% stake in the dr2013/4/11
-
FDA approves morning-sickness drug withdrawn in 1980s safety scareThe FDA has resurrected a morning-sickness treatment that went not-so-gently into the good night 30 years ago, on unfounded worries about birth defects. Diclegis, a tablet made by Canadian-based Duche2013/4/10
-
J&J releases more Doxil to the marketJohnson & Johnson ($JNJ) and the FDA sprang into action in 2011 when J&J's popular chemo drugDoxilbecame hard to get because of problems with the contract manufacturer. While the FDA looked fo2013/4/10
-
S&P doesn't buy AstraZeneca CEO's revamp planStandard & Poor's is not impressed with AstraZeneca's jump-start plan. The ratings agency cut the U.K.-based drugmaker's credit ratings, citing CEOPascal Soriot's strategy update last month,Reute2013/4/9
-
Roche inks $392M Huntington's disease pact with IsisRoche ($RHHBY) has stepped up with a $392 million deal designed to marry its work on new technology for delivering brain treatments with Isis' ($ISIS) antisense programs for Huntington's disease. In2013/4/9
-
Judge gives FDA 30 days to make Teva's Plan B available to adolescents OTCA federal judge has told the FDA to do exactly what the agency tried to do two years ago: make the "morning after"birth controlpill freely available to girls of all ages without a prescription. U.S2013/4/8
-
China obtains ISO/TC150/SC7 voting rightsOn March 26, 2013, the secretariat of Tissue Engineered Medical Products Subcommittee of National Technical Committee on Implants for Surgery and Orthopedic Devices of Standardization Administration2013/4/8
-
India's top court rebuffs Merck, lets generic Januvia roll outIndia's Supreme Court is keeping the pressure on Western drugmakers. Just days after invalidating a patent for Novartis' ($NVS) cancer drugGlivec, it has said a generic drugmaker there is free, for2013/4/7
-
Roche's Tamiflu, GSK's Relenza work against new bird flu strainChina will lean on the Roche ($RHHBY) drugTamifluto treat those infected with a new strain of bird flu that has so far sickened 16, killing 6. Authorities in Shanghai emphasized that the H7N9 virus i2013/4/7